Zinman, B., Schmidt, W., Moses, A., Lund, N., & Gough, S. (2012). Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme.
Παραπομπή σε μορφή Chicago (17η εκδ.)Zinman, B., W. Schmidt, A. Moses, N. Lund, και S. Gough. Achieving a Clinically Relevant Composite Outcome of an HbA1c of <7% Without Weight Gain or Hypoglycaemia in Type 2 Diabetes: A Meta-analysis of the Liraglutide Clinical Trial Programme. 2012.
Παραπομπή σε μορφή MLA (9th εκδ.)Zinman, B., et al. Achieving a Clinically Relevant Composite Outcome of an HbA1c of <7% Without Weight Gain or Hypoglycaemia in Type 2 Diabetes: A Meta-analysis of the Liraglutide Clinical Trial Programme. 2012.